Skip to main content
Premium Trial:

Request an Annual Quote

PacBio, Singapore's GIS Expand Collaboration on Infectious Disease

NEW YORK (GenomeWeb) – The Genome Institute of Singapore (GIS) and Pacific Biosciences today announced that they have expanded their collaboration on genomic analysis of infectious diseases.

Under the terms of the agreement, the partners will work to advance research in Singapore on infectious disease, genomics, sequencing analysis, and translational healthcare. Bacterial genomes are a particular focus of the collaboration, especially those that cause diarrhea, meningitis, and urinary tract infections, as well as those in human microbiomes.

"By acquiring a deeper understanding of bacterial genomes, we can tackle common infectious diseases and antibiotic resistance in an efficient manner, leading to better patient outcomes," GIS Executive Director Ng Huck Hui said in a statement.

The agreement builds on a relationship started earlier this year when PacBio collaborated with GIS scientists to study how Escherichia coli causes urinary tract infections.

GIS is part of Singapore's Agency for Science, Technology, and Research.